Literature DB >> 4215762

Opsonin system of the group B streptococcus.

J H Mathews, P H Klesius, R A Zimmerman.   

Abstract

The opsonization by polymorphonuclear leukocytes of group B streptococcal serotypes associated with neonatal sepsis and delayed meningitis was studied. A specific BIa opsonizing antibody (not related to the antipolysaccharide typing antibody) was present in only 10% of the population tested. Serotype BIa was not opsonized in the absence of this specific antibody. BIa antibody specificity was demonstrated by macroagglutination and absorption with BIa streptococci and extracts, but not by gel diffusion. The binding of complement by the BIa opsonin increased the mean phagocytic activity by 60%; complement was manifested via the classic and/or alternate C3-related pathway, but seldom by both concurrently. Serotypes BIb, BIc, BII, and BIII were naturally and nonspecifically opsonized in 95% of the human and baboon sera or plasma tested. Although similar levels of opsonization were present in hyperimmune rabbit sera, heat inactivation and homologous bacterial absorption did not reduce the level of phagocytic activity in the rabbit, human, or primate groups studied. These immunological studies confirmed previous findings that serotype BIa presents a serious hazard for neonatal sepsis, with a nearly 100% mortality. Exclusive isolation of BIII in delayed meningitis suggests that ingestion and subsequent killing by polymorphonuclear leukocytes of type III may differ from the other serotypes.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4215762      PMCID: PMC423105          DOI: 10.1128/iai.10.6.1315-1320.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.

Authors:  J A Winkelstein; H S Shin; W B Wood
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

2.  Impaired opsonic activity but normal phagocytosis in low-birth-weight infants.

Authors:  M L Forman; E R Stiehm
Journal:  N Engl J Med       Date:  1969-10-23       Impact factor: 91.245

3.  Serological relationships of type I antigens of group B streptococci.

Authors:  H W Wilkinson; M D Moody
Journal:  J Bacteriol       Date:  1969-02       Impact factor: 3.490

4.  Studies on interaction of bacteria, serum factors and polymorphonuclear leukocytes in mothers and newborns.

Authors:  J H Dossett; R C Williams; P G Quie
Journal:  Pediatrics       Date:  1969-07       Impact factor: 7.124

5.  Leukocyte function and the development of opsonic and complement activity in the neonate.

Authors:  G H McCracken; H F Eichenwald
Journal:  Am J Dis Child       Date:  1971-02

6.  Precipitating antibody to group A streptococcal polysaccharide in humans.

Authors:  R A Zimmerman; A H Auernheimer; A Taranta
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

7.  Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement.

Authors:  A P Dalmasso; H J Müller-Eberhard
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

8.  An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin.

Authors:  R L Marcus; H S Shin; M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

9.  Electron microscopic studies on streptococci. I. M antigen.

Authors:  J Swanson; K C Hsu; E C Gotschlich
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

10.  The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.

Authors:  R B Johnston; M R Klemperer; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  16 in total

1.  Group B streptococcal type Ia sepsis in mice after intranasal inoculation and the effect of infection on lungs.

Authors:  D E Wennerstrom
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

Review 2.  Group B streptococci in human disease.

Authors:  M J Patterson; A El Batool Hafeez
Journal:  Bacteriol Rev       Date:  1976-09

3.  The acquisition by the fetus of bacterial infection in pregnancy and labour.

Authors:  P A Davies
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1976

4.  Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.

Authors:  C J Baker; M S Edwards; B J Webb; D L Kasper
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

5.  Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.

Authors:  T I Doran; S J Mattingly
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

Review 6.  Phagocytosis. Clinical disorders of recognition and ingestion.

Authors:  T P Stossel
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

7.  Chicken embryo model for type III group B beta-hemolytic streptococcal septicemia.

Authors:  J Tieffenberg; L Vogel; R R Kretschmer; D Padnos; S P Gotoff
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

8.  Adult mice as a model for early onset group B streptococcal disease.

Authors:  D E Wennerstrom; R W Schutt
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

Review 9.  Neonatal streptococcal infections.

Authors:  M T Parker
Journal:  Postgrad Med J       Date:  1977-10       Impact factor: 2.401

10.  Extracellular neuraminidase production by group B streptococci.

Authors:  T W Milligan; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.